Delhi High Court writ petition seeking government funding for Zolgensma gene therapy worth ₹17.50 crore for a critically ill child. The Court converted the matter into a policy intervention, directing a high-level committee to reform the National Policy for Rare Diseases and its crowdfunding mechanisms.
This website is for informational purposes only and is not intended to advertise or solicit work as per the Bar Council of India rules. By accessing www.foresightlawoffices.com, you acknowledge that you are seeking information about Foresight Law voluntarily. Nothing on this site constitutes legal advice or creates a lawyer-client relationship. Foresight Law is not responsible for any actions taken based on the content here. External links do not imply endorsement. Please do not share confidential information via this website. For details, review our Privacy Policy and Terms of Use.